COVID-associated left atrial changes as a significant predictor of atrial fibrillation recurrence

Aim. To determine the prognostic significance of left atrial (LA) changes after SARS-CoV-2 infection on the atrial fibrillation recurrence rate after catheter ablation. Material and methods . The study involved 40 patients. All patients were monitored after 3, 6 and 12 months, as well as when the clinical performance of the disease changed. The average follow-up time was 19±3 months. Recurrence of atrial fibrillation was observed in 18 patients (45%). Results . The study groups were completely comparable in age (p=0,382), sex (p=0,604), arrhythmia type (p=0,842), and history of previous surgeries (p=0,949). Arrhythmia recurrence was 9,33 [2,18; 39,96] times more common in patients who had SARS-CoV-2 infection before surgery (p=0,01). Arrhythmia recurrence after catheter ablation caused by left atrial posterior wall fibrosis and without pulmonary vein reconnection is an independent risk factor for recurrence after another ablation attempt (p=0,020). Also, arrhythmia recurrence was 9 [2,09; 38,79] times more common in patients after left atrium posterior wall box isolation (p=0,002). About half of the atrial area in patients with arrhythmia recurrence is represented by myocardium with an amplitude of less than 0,25 mV. In patients without recurrence, the area with this amplitude is on average 15,9% smaller (49±18,4% and 33,1±17,5%, respectively; p=0,020). Differences in the myocardial area with an amplitude of less than 0,5 mV are more pronounced and average 21,4% (p=0,006). LA myocardial tissue with normal signal amplitude (>0,75 mV) is represented by only 17,4% of the area in patients with disease recurrence, which is 2,14 times less than in patients with remission (p=0,011). Conclusion . LA myocardial changes after SARS-CoV-2 infection are stable over time and significantly increase the arrhythmia recurrence risk after catheter ablation. Additional left atrial posterior wall box isolation does not reduce the risk of recurrence and does not significantly affect the duration of sinus rhythm control.

Authors

Institutions

Publication Details

Journal
Russian Journal of Cardiology
Published
2025-03-14
DOI
https://doi.org/10.15829/1560-4071-2025-5801
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID-associated left atrial changes as a significant predictor of atrial fibrillation recurrence

V. V. Semenyuta, Д. С. Лебедев, Anna Yu. Anisenkova, S. G. Shcherbak et al.
Russian Journal of Cardiology
Atrial Fibrillation Management and Outcomes
article

COVID-associated left atrial changes as a significant predictor of atrial fibrillation recurrence

V. V. Semenyuta, Д. С. Лебедев, Anna Yu. Anisenkova, S. G. Shcherbak, А. В. Каменев, Ан. М. Осадчий
article en

Abstract

Aim. To determine the prognostic significance of left atrial (LA) changes after SARS-CoV-2 infection on the atrial fibrillation recurrence rate after catheter ablation. Material and methods . The study involved 40 patients. All patients were monitored after 3, 6 and 12 months, as well as when the clinical performance of the disease changed. The average follow-up time was 19±3 months. Recurrence of atrial fibrillation was observed in 18 patients (45%). Results . The study groups were completely comparable in age (p=0,382), sex (p=0,604), arrhythmia type (p=0,842), and history of previous surgeries (p=0,949). Arrhythmia recurrence was 9,33 [2,18; 39,96] times more common in patients who had SARS-CoV-2 infection before surgery (p=0,01). Arrhythmia recurrence after catheter ablation caused by left atrial posterior wall fibrosis and without pulmonary vein reconnection is an independent risk factor for recurrence after another ablation attempt (p=0,020). Also, arrhythmia recurrence was 9 [2,09; 38,79] times more common in patients after left atrium posterior wall box isolation (p=0,002). About half of the atrial area in patients with arrhythmia recurrence is represented by myocardium with an amplitude of less than 0,25 mV. In patients without recurrence, the area with this amplitude is on average 15,9% smaller (49±18,4% and 33,1±17,5%, respectively; p=0,020). Differences in the myocardial area with an amplitude of less than 0,5 mV are more pronounced and average 21,4% (p=0,006). LA myocardial tissue with normal signal amplitude (>0,75 mV) is represented by only 17,4% of the area in patients with disease recurrence, which is 2,14 times less than in patients with remission (p=0,011). Conclusion . LA myocardial changes after SARS-CoV-2 infection are stable over time and significantly increase the arrhythmia recurrence risk after catheter ablation. Additional left atrial posterior wall box isolation does not reduce the risk of recurrence and does not significantly affect the duration of sinus rhythm control.

Russian Journal of CardiologyVol. 30(2)
Federal Almazov North-West Medical Research Centre (RU), City Hospital No. 40 (RU)
Openalex Percentile: Top 92%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.